Cite
Safety and Efficacy of CEEP (Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) with or without Rituximab in Elderly Patients (>70) with Diffuse Large B-Cell Lymphoma (DLBL): A Retrospective Single Center Experience
MLA
Hsu, Danny, et al. “Safety and Efficacy of CEEP (Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) with or without Rituximab in Elderly Patients (>70) with Diffuse Large B-Cell Lymphoma (DLBL): A Retrospective Single Center Experience.” Blood, vol. 118, no. 21, Nov. 2011, p. 4957. EBSCOhost, https://doi.org/10.1182/blood.V118.21.4957.4957.
APA
Hsu, D., Tohidi-Esfahani, I., Brown, C., Dunkley, S., Larsen, S. R., Ho, P. J., Iland, H., Gibson, J., & Joshua, D. E. (2011). Safety and Efficacy of CEEP (Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) with or without Rituximab in Elderly Patients (>70) with Diffuse Large B-Cell Lymphoma (DLBL): A Retrospective Single Center Experience. Blood, 118(21), 4957. https://doi.org/10.1182/blood.V118.21.4957.4957
Chicago
Hsu, Danny, Ibrahim Tohidi-Esfahani, Christina Brown, Scott Dunkley, Stephen Robert Larsen, Phoebe Joy Ho, Harry Iland, John Gibson, and Douglas E. Joshua. 2011. “Safety and Efficacy of CEEP (Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) with or without Rituximab in Elderly Patients (>70) with Diffuse Large B-Cell Lymphoma (DLBL): A Retrospective Single Center Experience.” Blood 118 (21): 4957. doi:10.1182/blood.V118.21.4957.4957.